A new treatment to combat heart failure works twice as well in women as it does in men, a study has found.
Researchers from the University of Rochester Medical Center investigated the effect of cardiac resynchronisation therapy with defibrillator (CRT-D).
It was found that the treatment led to a 70 per cent decrease in heart failure and a 72 per cent reduction in death among women, compared to a 35 per cent reduction in heart failure in men.
This is the first time a heart therapy has proved to be more effective in women than men.
Study author Dr Arthur Moss said: "It's not that men did poorly in the trial, but rather, women had really fantastic results, likely due to the type of heart disease we see more commonly in women."
This comes after a study, published in Circulation: Cardiovascular Genetics, found that the daughters of women who had a stroke are more prone to heart attacks and have a higher chance of experience a stroke themselves.